Literature DB >> 15047644

C-reactive protein and incident cardiovascular events among men with diabetes.

Matthias B Schulze1, Eric B Rimm, Tricia Li, Nader Rifai, Meir J Stampfer, Frank B Hu.   

Abstract

OBJECTIVE: Several large prospective studies have shown that baseline levels of C-reactive protein (CRP) are an independent predictor of cardiovascular events among apparently healthy individuals. However, prospective data on whether CRP predicts cardiovascular events in diabetic patients are limited so far. RESEARCH DESIGN AND METHODS: To investigate the association between plasma CRP levels and incidence of cardiovascular events among men with type 2 diabetes, we followed prospectively a cohort of 746 American men aged 46-81 years who were free of cardiovascular diseases at the time of blood collection in 1993-1994.
RESULTS: During an average of 5 years of follow-up (3,986 person-years), we identified 103 incident cardiovascular events (18 myocardial infarction, 70 coronary artery bypass grafting or angioplasty, and 15 stroke), confirmed by medical records. After adjustment for age, BMI, smoking, alcohol consumption, physical activity, family history of coronary heart disease, history of high blood pressure, history of high serum cholesterol, aspirin use, and fasting status as well as for fibrinogen, creatinine, HbA(1c), and non-HDL cholesterol levels, CRP remained significantly associated with an increased risk of cardiovascular events. The relative risks for quartiles were 1.00, 1.51, 2.52, and 2.62 (95% CI: 1.29-5.32; P for trend: 0.011). We observed no effect modifications by plasma levels of LDL cholesterol, HDL cholesterol, non-HDL cholesterol, apolipoprotein B, HbA(1c), and fibrinogen or by BMI.
CONCLUSIONS: High plasma levels of CRP were associated with an increased risk of incident cardiovascular events among diabetic men, independent of currently established lifestyle risk factors, blood lipids, and glycemic control.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15047644     DOI: 10.2337/diacare.27.4.889

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  41 in total

Review 1.  Atorvastatin: a review of its use in the primary prevention of cardiovascular events in patients with type 2 diabetes mellitus.

Authors:  Katherine F Croom; Greg L Plosker
Journal:  Drugs       Date:  2005       Impact factor: 9.546

Review 2.  Endothelial dysfunction in diabetes mellitus: molecular mechanisms and clinical implications.

Authors:  Corey E Tabit; William B Chung; Naomi M Hamburg; Joseph A Vita
Journal:  Rev Endocr Metab Disord       Date:  2010-03       Impact factor: 6.514

3.  Antisense to protein kinase C-alpha and p47phox attenuates the pro-inflammatory effects of human C-reactive protein in macrophages of biobreeding diabetic rats.

Authors:  Ishwarlal Jialal; Sridevi Devaraj
Journal:  Diab Vasc Dis Res       Date:  2012-07-16       Impact factor: 3.291

Review 4.  Type 2 diabetes and cardiovascular disease: Have all risk factors the same strength?

Authors:  Iciar Martín-Timón; Cristina Sevillano-Collantes; Amparo Segura-Galindo; Francisco Javier Del Cañizo-Gómez
Journal:  World J Diabetes       Date:  2014-08-15

Review 5.  Diabetes and ageing-induced vascular inflammation.

Authors:  Mariam El Assar; Javier Angulo; Leocadio Rodríguez-Mañas
Journal:  J Physiol       Date:  2015-11-02       Impact factor: 5.182

6.  Inflammation and Oxidative Stress in Cardiac Surgery Patients Treated to Intensive Versus Conservative Glucose Targets.

Authors:  David Reyes-Umpierrez; Georgia Davis; Saumeth Cardona; Francisco J Pasquel; Limin Peng; Sol Jacobs; Priyathama Vellanki; Maya Fayfman; Sonya Haw; Michael Halkos; Robert A Guyton; Vinod H Thourani; Guillermo E Umpierrez
Journal:  J Clin Endocrinol Metab       Date:  2017-01-01       Impact factor: 5.958

7.  Waist circumference and BMI in relation to serum high sensitivity C-reactive protein (hs-CRP) in Cuban Americans with and without type 2 diabetes.

Authors:  Fatma G Huffman; Suzanne Whisner; Gustavo G Zarini; Subrata Nath
Journal:  Int J Environ Res Public Health       Date:  2010-03-08       Impact factor: 3.390

8.  Antepartum pituitary necrosis occurring in pregnancy with uncontrolled gestational diabetes mellitus: a case report.

Authors:  Hyun Jong Park; Jinna Kim; Yumi Rhee; Yong Won Park; Ja-Young Kwon
Journal:  J Korean Med Sci       Date:  2010-04-16       Impact factor: 2.153

9.  The effects of rosiglitazone on inflammatory biomarkers and adipokines in diabetic, hypertensive patients.

Authors:  Milan Gupta; Hwee Teoh; Mahesh Kajil; Michelle Tsigoulis; Adrian Quan; Manoela Fb Braga; Subodh Verma
Journal:  Exp Clin Cardiol       Date:  2012

10.  C-reactive protein and 5-year survival in type 2 diabetes: the Casale Monferrato Study.

Authors:  Graziella Bruno; Paolo Fornengo; Giulia Novelli; Francesco Panero; Massimo Perotto; Olivia Segre; Chiara Zucco; PierCarlo Deambrogio; Giuseppe Bargero; Paolo Cavallo Perin
Journal:  Diabetes       Date:  2008-12-15       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.